article thumbnail

Patients Don’t Want to Be Sold. They Want the Truth.

World of DTC Marketing

Patients aren’t looking for a sales pitch. But patients live in a world of diagnoses, side effects, copays, and questions. What are the side effects?” “Can A brand that communicates honestly earns the trust of its patients. If it works better for some patients than others, be transparent about this.

article thumbnail

A New Era in Pharma DTC Marketing: Trust Over TV Spots

World of DTC Marketing

For decades, the image of pharmaceutical direct-to-consumer (DTC) marketing has been defined by glossy TV commercials: smiling patients, soft music, lengthy lists of side effects spoken at a rapid pace, and vague promises of a better life. Today’s patients don’t rely on a 60-second ad to make decisions about their health.

Marketing 252
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma’s TV Ads Burn Cash: Why Digital Wins

World of DTC Marketing

Let’s cut the pleasantries: pharma is burning cash on DTC TV ads while patients roll their eyes, change the channel, or fast-forward. What about patient action? A study in JAMA Network Open found that fewer than 7% of patients who saw a DTC ad asked their doctor about the advertised drug. adults trust pharmaceutical ads.

article thumbnail

It’s Time to Admit: In an Era of High Distrust, Pharma DTC TV Ads Are Ineffective

World of DTC Marketing

However, as the healthcare landscape continues to evolve—and trust in institutions declines—it’s time for the industry to confront a hard truth: DTC TV ads are no longer as effective as they once were. They may be increasingly out of step with how patients make healthcare decisions today. Instead, they pause. They question.

Pharma 206
article thumbnail

Ozempic: Weight Loss Miracle or Medical Mistake?

World of DTC Marketing

The weight loss side effect is real—but it’s just that: a side effect. Common side effects include nausea, vomiting, diarrhea, and fatigue. In plain English, it’s a medication that helps people with type 2 diabetes regulate blood sugar by enhancing insulin secretion, slowing digestion, and reducing appetite.

Medical 198
article thumbnail

The MEK effect on cancer — a slow and steady approach to drug resistance

PharmaVoice

Everyones focused on killing the tumor and the goal should really be to prevent the tumor from killing the patient,” Zeskind said. One downside for MEK inhibitors, however, is that patients eventually encounter resistance and a range of side effects. You can unsubscribe at anytime. Please let us know if you have feedback.

article thumbnail

What Happened to Pharma’s DTC Visionaries? Understanding Today’s Dull Ads

World of DTC Marketing

The first wave of DTC ads—think Pfizer’s Lipitor or Merck’s Vioxx—captivated audiences, defined brands, and revolutionized patient engagement. Drugs such as Lipitor, Viagra, and Nexium became household names, driven by groundbreaking marketing campaigns that genuinely connected with patients. The outcome?

Pharma 157